SCHEMBL2726536

SCHEMBL2726536

COc1ccc(-c2c3c(F)cccc3c(-c3ccc(F)c(F)c3)c3c(F)ccc(F)c23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.43
POLB P06746 1/20 0.41
STAT3 P40763 1/20 0.40
ACHE P22303 1/20 0.39
SYK P43405 1/20 0.38
MAOB P27338 1/20 0.38
ENPP1 P22413 1/20 0.37
ABL1 P00519 1/20 0.36
ABCB1 P08183 1/20 0.36
BCR P11274 1/20 0.36
MAPK13 O15264 2/20 0.36
MAPK12 P53778 2/20 0.36
MAPK11 Q15759 2/20 0.36
MAPK14 Q16539 2/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP2D6 P10635 1/20 0.36
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12086214 1.00 L3MBTL1 (0.43) L3MBTL1POLBSTAT3ACHESYK
SCHEMBL2731490 0.93 L3MBTL1 (0.40) L3MBTL1POLBSTAT3ACHESYK
SCHEMBL12086227 0.93 L3MBTL1 (0.40) L3MBTL1POLBSTAT3ACHESYK
SCHEMBL2710550 0.93 L3MBTL1 (0.42) L3MBTL1POLBSTAT3ACHESYK
SCHEMBL12086105 0.93 L3MBTL1 (0.42) L3MBTL1POLBSTAT3ACHESYK
SCHEMBL12086115 0.93 L3MBTL1 (0.44) L3MBTL1POLBSTAT3ACHESYK
SCHEMBL2710349 0.93 L3MBTL1 (0.44) L3MBTL1POLBSTAT3ACHESYK
SCHEMBL2727600 0.90 L3MBTL1 (0.39) L3MBTL1POLBSTAT3ACHESYK
SCHEMBL2727044 0.90 L3MBTL1 (0.48) L3MBTL1POLBSTAT3ACHESYK
SCHEMBL12086163 0.88 L3MBTL1 (0.37) L3MBTL1POLBSTAT3MAOBABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
EP-2445987-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS Cyalume Technologies, Inc (US) 2012-05-02 EP disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
WO-2010151654-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECHNOLOGIES, INC. (US) 2010-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYP2F1, FLAD1, AFF1 L3MBTL1 2477/4885POLB 3331/4885STAT3 3366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.